Gene therapy for spinomuscular atrophy: a biomedical advance, a missed opportunity for more equitable drug pricing
Crossref DOI link: https://doi.org/10.1038/gt.2017.48
Published Online: 2017-06-22
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Friedmann, T
Text and Data Mining valid from 2017-06-22
Version of Record valid from 2017-06-22
Article History
Received: 27 February 2017
Revised: 19 April 2017
Accepted: 26 April 2017
First Online: 22 June 2017
Competing interests
: The author declares no conflict of interest.